Press release
High Prevalence of Diabetes to be the Precursor for Growth of Global Oral Proteins and Peptides Market
Download Exclusive Sample of this Report: http://bit.ly/1Suvg8n
The global oral proteins and peptides market is thus catering to the vast needs of proteins and peptides that are required for treating various types of medical needs. The natural forms of proteins and peptides present in the body are responsible for regulating and protecting the bodily functions. They play a vital role in transporting oxygen and other substances through the body. Additionally, proteins and peptides also give the body a solid structure.
Q. What are the possible drivers for the global oral proteins and peptides market?
A. Transparency Market Research observes that increasing investments in research and development activities are expected to drive the growth of the market. The market will also be fueled by remarkable technological advancements, which have resulted in the development protein formulations that can be administered orally without any change in the pharmacokinetic aspects and therapeutic activity. The market is also thriving due to the high prevalence of chronic conditions across the globe.
Q. What are the drugs and technologies available in the global market?
A. The drugs available in the global oral proteins and peptides market are Plecantide, Linaclotide, Octreolin, IN-105 (inslulin), and Ostora amongst others. Analysts state that the majority of the molecules are being studied for the management of diabetes. Market research reveals that insulin is most popularly used product amongst all others due to the growing number diabetics around the world. However, pharmaceutical companies are also expected to focus on developing oral proteins and peptides for treating bone diseases and gastric disorders. The key technologies available in this market are Peptelligence, Gastrointestinal Permeation Enhancement Technology (GIPET), Eligen, Multi-Matrix Systems (MMX), and oral antibody platform.
Q. Who are the key players in the global market?
A. The leading players operating in the global oral proteins and peptides market are Pfizer, Inc., Sanofi-Aventis LLC, Roche, Inc., ZydusCadilla Healthcare, Johnson & Johnson, Novartis AG, and Abbott Laboratories amongst others. The growing investment from venture capitalists is yet another reason fuelling the growth of the global market. Product innovation and focus on delivering effective products is expected to be the main strategy for these players in the near future.
Browse Research Report: http://bit.ly/1NAHGE5
Despite the steady market drivers, the global oral proteins and peptides market faces some tough challenges such as high cost of research and development and the significant amount of capital required to set up businesses. Both of these factors has largely dissuaded new entrants from being a part of the market dynamics. However, innovations in the routes of administration of oral proteins and peptides such as inhalation, intranasal, and transdermal have opened up several growth opportunities for the global players in recent years.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High Prevalence of Diabetes to be the Precursor for Growth of Global Oral Proteins and Peptides Market here
News-ID: 373907 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
